Biocliq Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 1.00 M
as on 28-06-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 60.33%
(FY 2022)
- Profit 85.94%
(FY 2022)
- Ebitda 145.14%
(FY 2022)
- Net Worth 20.80%
(FY 2022)
- Total Assets 31.19%
(FY 2022)
About Biocliq Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Saikumar Dhandapani, Rengarajan Bashyam, and Nagabushanam Ravichandar serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC110239
- Company No.
110239
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biocliq Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saikumar Dhandapani  | Director | 29-May-2018 | Current |
| Rengarajan Bashyam | Director | 27-Apr-2021 | Current |
| Nagabushanam Ravichandar | Director | 18-Feb-2018 | Current |
Financial Performance and Corporate Structure Insights of Biocliq Technologies.
Biocliq Technologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.33% increase. The company also saw a substantial improvement in profitability, with a 85.94% increase in profit. The company's net worth Soared by an impressive increase of 20.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocliq Technologies?
Unlock access to Biocliq Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Right Prompt Technologies Private LimitedActive 1 year 4 monthsSaikumar Dhandapani is a mutual person
- Quraid Technologies India Private LimitedActive 3 years 10 months
Rengarajan Bashyam and Nagabushanam Ravichandar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biocliq Technologies?
Unlock and access historical data on people associated with Biocliq Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocliq Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocliq Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
